Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has announced the intimation of newspaper publication of information regarding the 58th Annual General Meeting through video conferencing/other audio visual means.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, disclosing its corporate identity, business activities, and sustainability initiatives.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has scheduled its 58th Annual General Meeting (AGM) on September 21, 2026, to consider re-appointment of directors, dividend declaration, and auditor re-appointment.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has announced its Annual Report for FY 2025-26, highlighting key operational and financial highlights, including the sale of land, successful launch of SAP S/4HANA, and initiation of project activities for a manufacturing facility. The company has also raised funds through a Qualified Institutional Placement and secured leasehold premises for an additional R&D centre in Hyderabad.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has announced the intimation of newspaper publication regarding the 58th Annual General Meeting through video conferencing/other audio visual means to be held on September 21, 2026.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd reported revenue from operations of INR293 crores and an EBITDA of INR98 crores for the quarter ended June 30, 2026, reflecting healthy sequential improvement. The company's PI vertical showed stronger performance, while the contrast media and high-intensity sweetener businesses provided stability and diversification.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has published unaudited standalone financial results for the quarter ended June 30, 2026, in accordance with Regulation 47 of the SEBI (LODR) Regulations, 2015.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has submitted the audio recording of its earnings conference call for the quarter ended June 30, 2026, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has released its Q1 FY27 financial results, showing a 25% increase in revenue from operations, 38% increase in EBITDA, and 22% increase in PAT. The company has also made progress in its growth strategy, with the R&D center on track to be operational by September 2026, and the Vizag project activities commenced. Additionally, the company has been awarded the Silver Medal by EcoVadis for its sustainability environment management practices.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has announced the outcome of its Board meeting, where it approved the re-appointment of Mr. Akshay B Arora as Whole Time Director and Executive Chairman, Mr. Shiven Akshay Arora as Managing Director, and M/s KKC & Associates LLP as Statutory Auditors. The company also declared a dividend of Rs. 1.2 per equity share for the financial year 2025-26 and fixed September 14, 2026, as the record date.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd announces unaudited standalone financial results for Q1 FY26, re-appointment of directors, and record date for dividend payment. The company also fixes September 14, 2026, as the record date for determining entitlement to receive a dividend of Rs. 1.2 per equity share.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has announced the outcome of its board meeting, which included the re-appointment of directors, approval of unaudited financial results for Q1 2026, and declaration of a 60% dividend for FY 2025-26. The company has also fixed a record date for the dividend and announced the date for its 58th Annual General Meeting.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd announced unaudited standalone financial results for the first quarter ended June 30, 2026, along with the re-appointment of directors, auditors, and the declaration of a dividend. The results and re-appointments are subject to shareholder approval at the ensuing Annual General Meeting.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has announced its unaudited standalone financial results for the first quarter ended June 30, 2026, and has also approved the re-appointment of its Whole Time Director and Executive Chairman, Managing Director, Statutory Auditors, and has fixed a record date for a dividend of Rs. 1.2 per equity share.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has scheduled an analyst and investor call on August 3, 2026, to discuss its unaudited standalone financial results for the quarter ended June 30, 2026.

Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd has scheduled a board meeting on August 3, 2026, to consider and approve unaudited standalone financial results for the first quarter ended June 30, 2026, along with a limited review report.